000 | 01285 a2200373 4500 | ||
---|---|---|---|
005 | 20250511222750.0 | ||
264 | 0 | _c19911007 | |
008 | 199110s 0 0 eng d | ||
022 | _a0956-960X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPower, D A | |
245 | 0 | 0 |
_aProduction of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology. _h[electronic resource] |
260 |
_bHuman antibodies and hybridomas _c1990 |
||
300 |
_a34-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcetylmuramyl-Alanyl-Isoglutamine |
650 | 0 | 4 | _aAdjuvants, Immunologic |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xbiosynthesis |
650 | 0 | 4 | _aAntibody Affinity |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 | _aCell Fusion |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aHLA-DR Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHybridomas _ximmunology |
650 | 0 | 4 |
_aImmunization _xmethods |
650 | 0 | 4 |
_aImmunoglobulin M _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aIsoantibodies _xbiosynthesis |
700 | 1 | _aGerkis, V | |
700 | 1 | _ad'Apice, A J | |
773 | 0 |
_tHuman antibodies and hybridomas _gvol. 1 _gno. 1 _gp. 34-41 |
|
999 |
_c2109503 _d2109503 |